Navigation Links
Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
Date:9/11/2007

MEDFORD, Mass., Sept. 11 /PRNewswire/ -- Serica Technologies, Inc., a growth-stage medical device company, has expanded its headquarters facilities, and recently completed the first manufacturing run of its novel biomaterial made from natural silk protein. Serica's new headquarters in Medford, MA, includes 22,000 square feet of state-of-the-art research and development laboratories, as well as manufacturing and administrative space. The facility is located convenient to Tufts University, where the company has ongoing collaborative research programs.

"This impressive facility is an excellent example of Massachusetts leading the way in this new century of the life sciences," said Senator Edward M. Kennedy. "Helping patients recover more quickly from surgery is an urgent medical need. The breakthrough new biomaterials being developed by Serica have great potential to improve the lives of countless patients across the country and throughout the world. I commend Serica for its pioneering new facility."

"We are entering an exciting new phase in the company's history, expanding our facilities and research programs to advance our technology platforms in orthopedic and reconstructive surgery, as well as a broad range of other applications in tissue repair," said Gregory H. Altman, Ph.D., President and CEO, Serica Technologies. "Serica is one of the few start-up companies committed to manufacturing -- we specialize in the proprietary processing of raw material to the packaging of finished product, combining state-of-the-art textile engineering and biomedical manufacturing capabilities."

Serica's new facilities feature nearly 12,000 square feet of research labs and a unique controlled environment manufacturing suite, which includes custom-designed textile processing equipment to achieve state-of-the-art production of its silk-based medical device product portfolio. Half of the company's 30 employees have received advanced scientific and medical degrees
'/>"/>

SOURCE Serica Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Barriers will not stop convergence of medical technologies
2. Merge Technologies net loss doubles to $10.1M
3. Making deals with evolving technologies in mind
4. Third Wave Technologies to raise $14.9M through private debt
5. Meier joins Broadlook Technologies as COO
6. Platypus Technologies secures $450K SBIR grant
7. Napier joins board of Third Wave Technologies
8. aOva Technologies raises $3 million
9. Consumer, business technologies face same challenges
10. Promega to get early access to WARF technologies under new agreement
11. Linda Weber to run Fiservs Interactive Technologies unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 ... auf    Richmond Pharmacology ist das erste ... Amyloidose-Zentrum am Royal Free Hospital in ... zur Untersuchung eines RNAi-Therapeutikums Studienversuche an einem Patienten ... von Transthyretin vermittelter Amyloidose entwickelt (ATTR), einer seltenen ...
(Date:3/29/2015)... , March 29, 2015 Caris ... important study data showing the presence of ... gynecologic cancer samples. Using Caris Molecular Intelligence®, ... researchers identified expression of programmed cell death ... of histology while its ligand (PD-L1) expression ...
(Date:3/27/2015)... März 2015  Peter Walter wurde als ... für seine bahnbrechende Arbeit ausgewählt, die sich ... werden, sowie für die Entschlüsselung der Komponenten ... Stress nutzen, der mit der Ansammlung von ... für Biochemie an der University of California, ...
(Date:3/27/2015)... , March 27, 2015 Working in ... Hospital in London , Richmond Pharmacology is ... global Phase 3 study for an investigational RNAi therapeutic being ... disease affecting the nerves and heart. Read ... Based at St Georges University of ...
Breaking Biology Technology:Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 4
... June 18 The first data to ... daily activities that are often impaired by pain related to ... 14th International Congress of Parkinson,s Disease and Movement Disorders in ... extension study showed that the efficacy of rotigotine remained stable ...
... ... will be attending their eighth (8th) consecutive ASMBS conference. , ... Irvine, CA (PRWEB) June 16, 2010 ... (8th) consecutive ASMBS conference. The Company will be located in Booth #115 and will ...
... ... of Maine (UMaine) were recently issued a patent approval for “Barrier Compositions and ... to the fluorocarbon compounds commonly used in food packaging. , ... Waterville, ME (Vocus) June ...
Cached Biology Technology:Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome 2Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome 3Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome 4Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome 5Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome 6Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome 7Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome 8Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome 9Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome 10Bariatric Advantage to Attend American Society of Metabolic and Bariatric Surgery (ASMBS) Conference 2Sustainable Technology Company Cerealus and University of Maine Issued Patent for "Barrier Compositions and Articles" 2
(Date:3/24/2015)... March 24, 2015   Crossmatch ™, a ... announced that its U.are.U ® 4500 Fingerprint ... Goorin Bros . to achieve PCI compliance for ... access to the POS terminal, protecting the retailer ... data breaches. With one-third of ...
(Date:3/23/2015)... Conn. , Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... new advertising campaign on CNBC television starting March 30 th ... will commence airing in New York ... Officer said: "We are excited about our new ad campaign ...
(Date:3/20/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) ... Global Strategic Business Report" report to their offering. ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... Latin America . Annual estimates and ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... recovered from the potentially deadly H5N1 strain of avian influenza ... according to an international team of researchers. In a study ... researchers have shown how specific antibodies taken from avian flu ... prove effective at neutralising the virus in culture vitro and ...
... basis by which pregnant women protect themselves against malaria ... to counteract this defence. The research could lead to ... Malaria is a parasitic disease spread by mosquitoes that ... the disease affects mostly children, malaria also severely affects ...
... most powerful genetic analysis of the DNA codes of ... cancer as well as those without the disease – ... individual’s risk for breast cancer. , In a paper ... team of scientists who conducted the genome-wide association study ...
Cached Biology News:Avian influenza survivors' antibodies effective at neutralising H5N1 strain 2HIV and malaria combine to adversely affect pregnant women and their infants 2First confirmed common genetic risk factors for breast cancer 2
... fixed-angle microcentrifuge rotor at RCF up ... filters consist of a membrane-containing filter ... filter by centrifugation for bacteria removal, ... of cells from media and DNA ...
... GeXP Genetic Analysis System provides high-throughput, quantitative ... The systems patented priming strategy overcomes ... analysis to just a few genes at ... genes per reaction and more samples per ...
... Chemicon Detergent-OUT Kit is a simple high ... solutions. Removes detergents without significant dilution ... protein solution on the Detergent-OUT Spin column ... The Med column is suitable for removing ...
... are derived from Paraffin embedded tissue blocks, ... procedures to ensure the highest quality. Tissues ... one block, sectioned at a thickness of ... Sections are large (3-5 mm in diameter) ...
Biology Products: